key: cord-0999370-4iz00n7g authors: Leng, Anli; Maitland, Elizabeth; Wang, Siyuan; Nicholas, Stephen; Liu, Rugang; Wang, Jian title: Individual Preferences for COVID-19 Vaccination in China date: 2020-12-05 journal: Vaccine DOI: 10.1016/j.vaccine.2020.12.009 sha: da0eab928d35d7f166a3fbc37db6dc5e5ab6922c doc_id: 999370 cord_uid: 4iz00n7g Background Vaccinations are an effective choice to stop disease outbreaks, including COVID-19. There is little research on individuals' COVID-19 vaccination decision-making. Objective We aimed to determine individual preferences for COVID-19 vaccinations in China, and to assess the factors influencing vaccination decision-making to facilitate vaccination coverage. Methods A D-efficient discrete choice experiment was conducted across six Chinese provinces selected by the stratified random sampling method. Vaccine choice sets were constructed using seven attributes: vaccine effectiveness, side-effects, accessibility, number of doses, vaccination sites, duration of vaccine protection, and proportion of acquaintances vaccinated. Conditional logit and latent class models were used to identify preferences. Results Although all seven attributes were proved to significantly influence respondents’ vaccination decision, vaccine effectiveness, side-effects and proportion of acquaintances vaccinated were the most important. We also found a higher probability of vaccinating when the vaccine was more effective; risks of serious side effects were small; vaccinations were free and voluntary; the fewer the number of doses; the longer the protection duration; and the higher the proportion of acquaintances vaccinated. Higher local vaccine coverage created altruistic herd incentives to vaccinate rather than free-rider problems. The predicted vaccination uptake of the optimal vaccination scenario in our study was 84.77%. Preference heterogeneity was substantial. Individuals who were older, had a lower education level, lower income, higher trust in the vaccine and higher perceived risk of infection, displayed a higher probability to vaccinate. Conclusions Preference heterogeneity among individuals should lead health authorities to address the diversity of expectations about COVID-19 vaccinations. To maximize COVID-19 vaccine uptake, health authorities should promote vaccine effectiveness; pro-actively communicate the absence or presence of vaccine side effects; and ensure rapid and wide media communication about local vaccine coverage. By the end of July, 2020, COVID-19 had infected more than 16 million people across 216 countries or territories, with more than 65,000 deaths worldwide [1] . During the pandemic, there have been no specific antiviral drugs to treat COVID-19 effectively, but existing drugs used to treat other viral diseases, such as dexamethasone, have improved the recovery of high-risk COVID-19 patients. A vaccine is seen as the effective choice to stop the pandemic, with more than 100 COVID-19 vaccines in development worldwide [2] , including seven that have now been approved for human testing through clinical trials. Three vaccines are awaiting regulatory approval in the U.S. and U.K, and China and Russia are at an advanced stage of COVID-19 vaccine approval. With the hope that a COVID-19 vaccine will be approved in the near future, it is vital to understand individuals' vaccination preferences and vaccination decision-making in order to predict vaccination coverage, to assess the factors influencing vaccination decision-making, and to improve COVID-19 vaccination coverage. There is little research on individuals' COVID-19 vaccination decision-making. To addresses this lacuna, we test an individual choice COVID-19 vaccination model across six provinces in China. Previous research using health belief models found that only 48.2% of Chilean population reported a definite intent to receive the COVID-19 vaccine, 46.1% with a probable intent or a possible intent [3] . Research suggests that the novelty of the disease may lead to individuals indicating reluctance to get vaccinated [4] . Previous studies of vaccine uptake identified various vaccine-specific factors that influence an individual's vaccination preferences, such as the vaccine's side effects, effectiveness, duration of protection, cost, number of doses, transmission route, location of vaccination sites, willingness to pay and the burden of the disease [3] [4] [5] [6] [7] [8] [9] [10] [11] . There is no agreement on the importance of these vaccine-specific aspects on the willingness to vaccinate. Also, there is no consensus on whether vaccine-led herd immunity leads to higher vaccine acceptance through altruistic motives [10, 12] or hinders individual vaccinations through the free-rider problem [9] . Further, inter-individual vaccination preference heterogeneity may impact vaccine uptake depending on individuals' socio-demographic characteristics, such as age, education [10] and income [11, 12] . Also, trust in the vaccine and social trust may be important factors in individual heterogeneity, because they influence people's decision to vaccinate, especially given that many vaccines have a reputation for poor quality, leading to a drop in vaccine coverage [13, 14] . Widely employed in studies of the hepatitis B virus (HBV) [5, 7] , seasonal influenza [4] and human papillomavirus vaccines [7] , we used the discrete choice experiment (DCE) method to reveal and measure preferences for a potential COVID-19 vaccine. The conditional logit model (CLM) was used to test whether respondents' predefined characteristics alter the mean preference associated with attribute values. In addition, the latent class model (LCM) was used to estimate inter-individual preference heterogeneity. Our study is one of the first attempts to determine the preferences of individuals in China for a COVID-19 vaccine. While a China-based study, the research will inform other countries on individual COVID-19 decision-making, facilitating vaccination coverage in line with China and World Health Organization goals. Identification of vaccine attributes and their levels is key for ensuring the validity of DCE. We retrieved relevant vaccine attributes and levels from the literature [3] [4] [5] [6] [7] 10, 15] . Attributes were then ranked, categorized and reduced through interviews with a group of eight experts in the field of vaccination, an eight person focus group discussion and a 30 survey pilot study. We identified seven key attributes and adopted a DCE design with 8 choice sets of two vaccine profiles. The details of the attributes and levels are displayed in Table 1 . Vaccine effectiveness refer to the proportion of vaccinated persons protected by the vaccine, with three levels (40%, 60% and 85%), based on the effectiveness of seasonal influenza vaccinations [16, 17] and high effectiveness of H1N1 vaccination [18] . Side effects were assigned three levels: 50/100000, 10/100000 and 1/100000. These levels were chosen to represent vaccines with moderate side effects, such as seasonal influenza vaccines [16, 17] and low side effects, such as H1N1 vaccine [19] . Access to the vaccine was specified as free and voluntary (reflecting H1N1 vaccination), free and compulsory (reflecting most current universal childhood vaccinations) and chargeable and voluntary (reflecting some partial or non-reimbursed seasonal influenza vaccines). Number of doses was described by two levels: one dose and two or more doses. Vaccination sites were described by three possible levels: village clinic or community health station, township or community health centre, and county hospital and above. The duration of vaccine protection was assigned three levels: 6 months, 1 year and two or more years. These duration levels were retrieved based on the duration of vaccine protection of seasonal influenza vaccinations [16, 17] , H1N1 vaccination [18] and hepatitis B vaccine [5] . Acquaintances vaccinated was assigned 30%, 60% and 90% of close acquaintances (friends and family) already being vaccinated. This attribute was to quantify the importance of local coverage as a main driver for vaccination choices [6] . To guarantee that preference parameters can be estimated with maximal precision, the D-efficient partial profile design was used. Forty-eight hypothetical two-alternative choice tasks were created in STATA 15.0. For each choice task, respondents were asked to choose which vaccine they would prefer. To reduce the cognitive burden on respondents, these 48 choice tasks were divided randomly into 6 different versions of the questionnaire. As shown in the examples in Figure 1 , each version included 8 choice tasks. A three-part questionnaire sought information on respondents' background characteristics, attitudes to COVID-19 and the COVID-19 vaccine, and DCE preferences. Background characteristics comprised sex, age, location, educational attainment, job status, and income. Using a five-point Likert scale, attitudes to COVID-19 were surveyed by two questions and attitudes to the COVID-19 vaccine were surveyed by six questions as show in Appendix 1 Supplemental Material. Vaccine and COVID-19 related attitudes were tested as covariates with the DCE estimates to examine preference heterogeneity. A pilot survey was conducted with 30 respondents. Based on the pilot, the survey was subsequently revised to improve phraseology and question layout. Also, the pilot allowed the survey to be adjusted to ease the cognitive load and to increase the quality of the responses, with 48 pairs of scenarios in the questionnaires divided into 6 questionnaires with 8 pairs of scenarios in each. To promote survey accuracy, our DCE started with a general description and an illustrative example of a simplified choice set to familiarize the respondents with the choice tasks ahead. The study was approved by Nanjing Medical University Ethics Committee (No.2020565) and the face-to-face survey conducted by trained researchers. Using a stratified random sampling method, six Chinese provinces were chosen based on high, medium and low GDP per capita, geographically covering east, central and west regions of China. In each province, three cities were chosen, also divided into high, medium and low GDP per capita, with 314 individuals randomly surveyed in each city. The inclusion criteria were respondents aged over 18 years old, without cognitive impairments. According to the research standard proposed by Orme [20] , the minimum sample size should be 94, with de Bekker-Grop et al. reporting from a DCE literature survey that only 9% of DCE sample sizes were greater than 10000 [21] . Our study collected 1888 questionnaires, with 1883 (99.7%) of respondents answering all choices. The six versions of the questionnaires were evenly distributed, with version 1 accounting for 17.21%, version 2, 16.46%, version 3, 17.05%, version 4, 16.09%, version 5, 15.93% and version 6, 17.26% of all surveys. In total, 30128 observations comprised the database. Following previous research [22] , all the variables describing attribute levels were introduced as dummy variables. The quality of the various discrete choice models was compared on the basis of the Bayesian information criteria (BIC) and Akaike information criteria (AIC) [23] . The preferences were estimated with two models, the conditional logit model (CLM) and latent class model (LCM where is the utility of respondent i for scenario j in the choice set s (here j = 1, 2; s = ijs U 1,.., 8) , is a parameter vector relating attribute values and utility levels and is error of CLM assumes errors are independent and identically distributed, which limits the analysis of response heterogeneity and neglects preference heterogeneity. Not conforming to CLM model assumptions, LCM addresses these problems by classifying individuals into mutually exclusive groups, which display heterogeneous preferences, according to differences in share values, characteristics and behavior. The AIC and BIC criteria were used to determine the optimal number of classes [24] . The optimal utility function was: where represents the utility of respondent i belonging to class segment c for scenario j in c ijs U | choice sets. In addition to the utility function, the final model allowed for several covariates (age, education, region, income, trust in vaccines, and risk of infection) to enter into the class assignment model. The class assignment utility function for the final model was: Policy analysis was conducted by calculating the probability of vaccine uptake. Utility scores were used as probabilities and attribute levels were predefined. Probabilities of vaccine uptake were calculated on the basis of an indirect utility analysis, using equation 1, whereby individual (n) will choose vaccine within a choice set of 1 out of j sets (j =1,... j) of options. Table 3 presents the respondents' characteristics. Of the 1883 respondents, 50.98% were female and 60.33% live in urban areas, which was consistent with the current national population distribution making the sample broadly nationally representative. Key characteristics include 61.23% in the 18-44 age group; 59.27% were married; about 70% had a high school (9